Copertina

Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kathryn Sine, Thomas Lavoie, Aisling R. Caffrey, Vrishali V. Lopes, David Dosa, Kerry L. LaPlante, Haley J. Appaneal
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Expert consensus recommendations for innovative antiretroviral drugs
di: C. Lindsay DeVane
Pubblicazione: (2024)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study
di: Maria‐Stephanie A. Hughes, et al.
Pubblicazione: (2024)

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
di: Erika L. Hellenbart, et al.
Pubblicazione: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
di: Mohammed Aldhaeefi, et al.
Pubblicazione: (2024)

Assessment of the association between mixed‐oil lipid injectable emulsion use and 30‐day mortality or infection persistence from fungal catheter‐related bloodstream infections in pediatric patients following receipt of parenteral nutrition: A retrospective cohort study
di: Gustavo R. Alvira‐Arill, et al.
Pubblicazione: (2025)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
di: David B. Cluck, et al.
Pubblicazione: (2024)

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta‐analysis
di: Dongjun Xu, et al.
Pubblicazione: (2024)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
di: Christen J. Arena, et al.
Pubblicazione: (2025)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
di: Candice L. Garwood, et al.
Pubblicazione: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
di: Elmar R. Alizadeh, et al.
Pubblicazione: (2024)

Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
di: Melissa N. W. Jackson, et al.
Pubblicazione: (2024)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
di: Elizabeth M. Sherman, et al.
Pubblicazione: (2024)

Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Pubblicazione: (2024)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)

In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
di: Trisha Matsuura, et al.
Pubblicazione: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
di: Amira R. Rashdan, et al.
Pubblicazione: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
di: Kathleen A. Stringer, et al.
Pubblicazione: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
di: Shibing Tao, et al.
Pubblicazione: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
di: Ashlan J. Kunz Coyne, et al.
Pubblicazione: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
di: Jennifer N. Clements, et al.
Pubblicazione: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
di: Susan E. Smith, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
di: Mathieu Blouin, et al.
Pubblicazione: (2024)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
di: Amy Broadwater, et al.
Pubblicazione: (2026)